Lowering HbA1c Through Diet: What the UK Evidence Actually Shows

Type 2 diabetes (T2D) now affects roughly 4.4 million people in the UK, with another 1.2 million estimated to be undiagnosed.[1] HbA1c — average blood glucose over the previous 8–12 weeks — is the single most useful number we work with in clinic. Lower it sustainably and the long-term risk of retinopathy, nephropathy, and major cardiovascular events falls in proportion. The good news, supported by a large body of UK trial evidence, is that diet alone can move HbA1c meaningfully — and in some cases, push T2D into remission.

The most important UK trial on this topic is DiRECT (Diabetes Remission Clinical Trial), a primary care-led, cluster-randomised study published in The Lancet in 2018, with two-year follow-up in Lancet Diabetes & Endocrinology in 2019.[2,3] Participants with T2D of up to six years' duration followed a structured low-energy formula-based diet (~825–853 kcal/day) for 12–20 weeks, then a stepped reintroduction of food with ongoing dietetic support. At one year, 46% of the intervention group were in remission (HbA1c <6.5% off all glucose-lowering medication for at least two months) versus 4% in standard care; at two years, 36% remained in remission.[2,3] Remission was strongly dose-related to weight loss: 64% of participants who lost ≥10 kg were in remission at two years.

DiRECT does not mean every T2D client should jump on a formula diet. NICE NG28 — the current UK guideline for managing T2D in adults — recommends individualised dietary advice from a registered dietitian, with no single "diabetes diet" prescribed for everyone.[4] Mediterranean-style, low-carbohydrate, and DASH patterns all have evidence in the right context. Diabetes UK's 2024 position is similar: a low-carbohydrate diet (typically 50–130 g of carbohydrate per day) is a safe and effective option for many adults with T2D, particularly those who are overweight, but should be planned with a dietitian and monitored when the client is on insulin or sulphonylureas.[5]

In day-to-day clinical practice, three dietary moves carry most of the HbA1c benefit. First, the volume of refined carbohydrate goes down — fewer sugary drinks, white bread, and ultra-processed snacks; more pulses, oats, and intact whole grains. Second, protein and fibre at every main meal blunt the postprandial glucose spike, regardless of whether the overall pattern is low-carb or Mediterranean. Third, body weight comes down by 5–15% over six to twelve months in most clients who engage with structured support — and weight is the single biggest lever on HbA1c in T2D.

Two cautions worth flagging. Glucose-lowering medications (especially insulin and sulphonylureas) often need to be reduced as carbohydrate intake drops, otherwise hypoglycaemia is a real risk; this is something we always coordinate with your GP or diabetes specialist nurse. And remission, while real, is not always durable — DiRECT's five-year follow-up suggests that long-term remission depends heavily on continued weight maintenance and ongoing structured support.[6] Treating T2D as a one-off "fix" rather than an ongoing condition you actively manage is the most common path back to medication.

If your most recent HbA1c is sitting above target (typically ≥48 mmol/mol on lifestyle, ≥53 mmol/mol on medication, depending on your individual care plan), there is a strong evidence-based case for dedicated dietetic input. The discovery call is free — bring your last few blood test results and current medication list, and we will agree on a plan that fits your situation.